Stephen R. Wedge
Newcastle University(GB)
Publications by Year
Research Areas
Angiogenesis and VEGF in Cancer, Cancer, Hypoxia, and Metabolism, PI3K/AKT/mTOR signaling in cancer, Cancer-related Molecular Pathways, Cancer Treatment and Pharmacology
Most-Cited Works
- → Guidelines for the welfare and use of animals in cancer research(2010)1,429 cited
- → Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials(1997)807 cited
- ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration.(2002)
- → AZD2171: A Highly Potent, Orally Bioavailable, Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitor for the Treatment of Cancer(2005)709 cited
- → AZD1152, a Selective Inhibitor of Aurora B Kinase, Inhibits Human Tumor Xenograft Growth by Inducing Apoptosis(2007)356 cited
- → Clinical development of new drug–radiotherapy combinations(2016)312 cited
- → Novel 4-Anilinoquinazolines with C-7 Basic Side Chains: Design and Structure Activity Relationship of a Series of Potent, Orally Active, VEGF Receptor Tyrosine Kinase Inhibitors